Thailand-based Bangkok Bank Public Company Ltd and Reignwood Group were part of a consortium who invested in a $150-million committed series B stock financing round of Humacyte Inc, a US-based innovator in biotechnology and regenerative medicine.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
